Top Buy
| Security ▼ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Puma Biotechnology Inc. | 2 | 0 | 2 | 0 | €3.41 | €6.00 | 75.953% |
| Pulmatrix Inc. | 2 | 1 | 1 | 0 | €1.84 | €6.08 | 230.272% |
| PTC Therapeutics Inc. | 13 | 9 | 0 | 0 | €28.80 | €41.41 | 43.797% |
| Prothena Corp. plc | 12 | 0 | 1 | 0 | €18.10 | €79.47 | 339.038% |
| Precision BioSciences Inc | 8 | 0 | 0 | 0 | €0.35 | €10.38 | 2881.839% |
| Phibro Animal Health Corp. A | 3 | 2 | 0 | 0 | €15.70 | €12.06 | -23.159% |
| Pfizer Inc. | 29 | 4 | 3 | 0 | €26.37 | €41.51 | 57.423% |
| Personalis Inc | 8 | 1 | 0 | 0 | €2.64 | €3.26 | 23.565% |
| Pacira Pharmaceuticals | 22 | 0 | 4 | 0 | €19.80 | €41.36 | 108.909% |
| Omeros Corp. | 2 | 4 | 0 | 0 | €3.81 | - | - |
| Novocure Ltd | 1 | 1 | 0 | 0 | €17.80 | - | - |
| Novavax Inc. | 5 | 1 | 1 | 1 | €9.91 | €22.91 | 131.181% |
| Neurocrine Bioscience | 42 | 0 | 12 | 0 | €132.05 | €149.47 | 13.193% |
| Nektar Therapeutics | 4 | 1 | 0 | 0 | €1.09 | €2.40 | 119.982% |
| Merck & Co. Inc. | 33 | 1 | 4 | 0 | €103.00 | €125.72 | 22.057% |
| Medpace Holdings Inc | 16 | 0 | 5 | 0 | €334.30 | €418.12 | 25.074% |
| MannKind Corp. | 9 | 0 | 0 | 0 | €4.58 | €6.43 | 40.430% |
| Madrigal Pharmaceuticals inc. | 3 | 0 | 0 | 0 | €211.10 | €315.00 | 49.218% |
| MacroGenics Inc. | 13 | 0 | 2 | 0 | €3.12 | €11.86 | 279.555% |
| Krystal Biotech | 17 | 0 | 1 | 0 | €158.15 | €180.00 | 13.816% |
| Kala Pharmaceuticals Inc. | 5 | 0 | 0 | 0 | €5.32 | €19.50 | 266.513% |
| Johnson & Johnson | 41 | 1 | 7 | 0 | €145.18 | €196.23 | 35.164% |
| Iovance Biotherapeutics Inc. | 22 | 2 | 0 | 0 | €6.71 | €26.25 | 291.385% |
| Ionis Pharmaceuticals Inc. | 28 | 6 | 8 | 1 | €42.48 | €56.72 | 33.525% |
| Intra-Cellular Therapies Inc. | 28 | 0 | 1 | 0 | €66.50 | €84.46 | 27.002% |